Galena Biopharma Inc Share Price Nasdaq
Equities
US3632561086
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Sales 2024 * | - | Sales 2025 * | 50.61M 4.22B | Capitalization | 69.77M 5.82B |
---|---|---|---|---|---|
Net income 2024 * | -40M -3.34B | Net income 2025 * | -50M -4.17B | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 1.38 x |
P/E ratio 2024 * |
-1.09
x | P/E ratio 2025 * |
-1.08
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.5% |
Latest transcript on Galena Biopharma Inc
Managers | Title | Age | Since |
---|---|---|---|
Angelos Stergiou
FOU | Founder | 48 | 03/06/03 |
John Burns
DFI | Director of Finance/CFO | 39 | 01/13/01 |
Andrew Elnatan
LAW | General Counsel | - | 05/23/05 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 67 | 29/17/29 | |
David Scheinberg
BRD | Director/Board Member | 68 | 01/17/01 |
John Varian
BRD | Director/Board Member | 64 | 29/17/29 |
1st Jan change | Capi. | |
---|---|---|
-3.46% | 102B | |
+1.41% | 96.29B | |
+2.13% | 22.18B | |
-15.84% | 21.2B | |
-9.21% | 18.31B | |
-39.98% | 17.38B | |
-14.65% | 16.36B | |
+4.39% | 13.97B | |
+31.35% | 12.17B |